Literature DB >> 21987778

Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry.

Lawrence W Leung1, Osvaldo Martinez, Olivier Reynard, Viktor E Volchkov, Christopher F Basler.   

Abstract

We examined the ability of the Ebola virus to elicit an antiviral response from plasmacytoid dendritic cells (pDCs). Exposure of pDCs to Ebola virus did not result in significantly higher levels of interferon-α production than the levels in mock-infected cells. After inoculation with Ebola virus under the same conditions, conventional dendritic cells expressed viral proteins whereas pDCs did not, suggesting that the latter cells were not infected. Assessment of the entry of Ebola virus-like particles into pDCs revealed that pDCs are highly impaired for viral entry in comparison with conventional dendritic cells. These observations identify a novel means by which Ebola virus can avoid triggering an antiviral response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987778      PMCID: PMC3189990          DOI: 10.1093/infdis/jir331

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro.

Authors:  M Gupta; S Mahanty; R Ahmed; P E Rollin
Journal:  Virology       Date:  2001-05-25       Impact factor: 3.616

2.  A system for functional analysis of Ebola virus glycoprotein.

Authors:  A Takada; C Robison; H Goto; A Sanchez; K G Murti; M A Whitt; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

3.  Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Authors:  Asuka Nanbo; Masaki Imai; Shinji Watanabe; Takeshi Noda; Kei Takahashi; Gabriele Neumann; Peter Halfmann; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

5.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

6.  Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.

Authors:  Catharine M Bosio; M Javad Aman; Case Grogan; Robert Hogan; Gordon Ruthel; Diane Negley; Mansour Mohamadzadeh; Sina Bavari; Alan Schmaljohn
Journal:  J Infect Dis       Date:  2003-11-14       Impact factor: 5.226

7.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Authors:  Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.

Authors:  Amy L Hartman; Brian H Bird; Jonathan S Towner; Zoi-Anna Antoniadou; Sherif R Zaki; Stuart T Nichol
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

9.  Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus.

Authors:  Hannah Phipps-Yonas; Jeremy Seto; Stuart C Sealfon; Thomas M Moran; Ana Fernandez-Sesma
Journal:  PLoS Pathog       Date:  2008-10-31       Impact factor: 6.823

10.  The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand.

Authors:  G Grouard; M C Rissoan; L Filgueira; I Durand; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

View more
  10 in total

1.  A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.

Authors:  Mukta Dutta; Shelly J Robertson; Atsushi Okumura; Dana P Scott; Jean Chang; Jeffrey M Weiss; Gail L Sturdevant; Friederike Feldmann; Elaine Haddock; Abhilash I Chiramel; Sanket S Ponia; Jonathan D Dougherty; Michael G Katze; Angela L Rasmussen; Sonja M Best
Journal:  Cell Rep       Date:  2017-01-17       Impact factor: 9.423

2.  Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.

Authors:  James Duehr; Teddy John Wohlbold; Lisa Oestereich; Veronika Chromikova; Fatima Amanat; Madhusudan Rajendran; Sergio Gomez-Medina; Ignacio Mena; Benjamin R tenOever; Adolfo García-Sastre; Christopher F Basler; Cesar Munoz-Fontela; Florian Krammer
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

3.  Immunologic timeline of Ebola virus disease and recovery in humans.

Authors:  Anita K McElroy; Rama S Akondy; David R Mcllwain; Han Chen; Zach Bjornson-Hooper; Nilanjan Mukherjee; Aneesh K Mehta; Garry Nolan; Stuart T Nichol; Christina F Spiropoulou
Journal:  JCI Insight       Date:  2020-05-21

Review 4.  Filovirus Strategies to Escape Antiviral Responses.

Authors:  Judith Olejnik; Adam J Hume; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler; Elke Mühlberger
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 5.  Correlates of immunity to filovirus infection.

Authors:  Steven B Bradfute; Sina Bavari
Journal:  Viruses       Date:  2011-06-27       Impact factor: 5.048

Review 6.  The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.

Authors:  Osvaldo Martinez; Lawrence W Leung; Christopher F Basler
Journal:  Antiviral Res       Date:  2012-02-08       Impact factor: 5.970

Review 7.  Ebola Virus Disease in Humans: Pathophysiology and Immunity.

Authors:  César Muñoz-Fontela; Anita K McElroy
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

8.  Quantification of Type I Interferon Inhibition by Viral Proteins: Ebola Virus as a Case Study.

Authors:  Macauley Locke; Grant Lythe; Martín López-García; César Muñoz-Fontela; Miles Carroll; Carmen Molina-París
Journal:  Viruses       Date:  2021-12-04       Impact factor: 5.048

Review 9.  Forty-five years of Marburg virus research.

Authors:  Kristina Brauburger; Adam J Hume; Elke Mühlberger; Judith Olejnik
Journal:  Viruses       Date:  2012-10-01       Impact factor: 5.048

Review 10.  When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses.

Authors:  Daniel Perez-Zsolt; Javier Martinez-Picado; Nuria Izquierdo-Useros
Journal:  Viruses       Date:  2019-12-19       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.